Isabelle Plo

8.9k total citations
99 papers, 3.4k citations indexed

About

Isabelle Plo is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Isabelle Plo has authored 99 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 57 papers in Genetics and 53 papers in Hematology. Recurrent topics in Isabelle Plo's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (53 papers), Acute Myeloid Leukemia Research (29 papers) and Kruppel-like factors research (25 papers). Isabelle Plo is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (53 papers), Acute Myeloid Leukemia Research (29 papers) and Kruppel-like factors research (25 papers). Isabelle Plo collaborates with scholars based in France, Belgium and United States. Isabelle Plo's co-authors include William Vainchenker, Bernard S. López, Caroline Marty, Emilie Rass, Pascale Bertrand, Éric Solary, Stefan N. Constantinescu, Jean‐Luc Villeval, Hana Raslová and Guy Laurent and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Isabelle Plo

98 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Plo France 30 2.3k 1.4k 1.4k 650 396 99 3.4k
Frédéric Larbret France 20 1.1k 0.5× 569 0.4× 746 0.5× 357 0.5× 197 0.5× 32 2.0k
Stany Chrétien France 29 1.9k 0.9× 506 0.4× 873 0.6× 970 1.5× 179 0.5× 64 3.4k
Claudia Scholl Germany 32 2.7k 1.2× 676 0.5× 2.0k 1.4× 688 1.1× 64 0.2× 72 4.2k
Shannon Elf United States 20 1.8k 0.8× 431 0.3× 722 0.5× 408 0.6× 104 0.3× 33 2.6k
Martin Ruthardt Germany 33 3.2k 1.4× 380 0.3× 2.0k 1.4× 547 0.8× 118 0.3× 85 3.9k
Matthew R. Warr United States 17 1.6k 0.7× 454 0.3× 876 0.6× 383 0.6× 69 0.2× 30 2.9k
Rebecca J. Chan United States 32 2.2k 1.0× 349 0.2× 580 0.4× 531 0.8× 129 0.3× 90 3.3k
Jacqueline E. Damen Canada 25 2.2k 1.0× 483 0.3× 489 0.3× 887 1.4× 230 0.6× 42 3.9k
Hanna S. Radomska United States 29 2.4k 1.1× 345 0.2× 1.6k 1.1× 455 0.7× 57 0.1× 58 3.7k
Diana Linnekin United States 23 839 0.4× 377 0.3× 547 0.4× 532 0.8× 160 0.4× 40 2.0k

Countries citing papers authored by Isabelle Plo

Since Specialization
Citations

This map shows the geographic impact of Isabelle Plo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Plo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Plo more than expected).

Fields of papers citing papers by Isabelle Plo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Plo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Plo. The network helps show where Isabelle Plo may publish in the future.

Co-authorship network of co-authors of Isabelle Plo

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Plo. A scholar is included among the top collaborators of Isabelle Plo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Plo. Isabelle Plo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loyau, Stéphane, Dorothée Faille, Juliette Gay, et al.. (2024). Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms. Journal of Thrombosis and Haemostasis. 22(11). 3199–3208. 1 indexed citations
2.
Muller, Delphine, Laure Gilles, Mira El-Khoury, et al.. (2024). Deregulation of the p19/CDK4/CDK6 axis in Jak2V617F megakaryocytes accelerates the development of myelofibrosis. Leukemia. 38(4). 898–902. 1 indexed citations
3.
Boët, Emeline, Ambrine Sahal, Estelle Saland, et al.. (2023). Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms. Blood Cancer Journal. 13(1). 106–106. 8 indexed citations
4.
Pasquier, Florence, Christophe Marzac, Éric Deconinck, et al.. (2022). An inherited gain‐of‐function risk allele in EPOR predisposes to familial JAK2V617F myeloproliferative neoplasms. British Journal of Haematology. 198(1). 131–136. 7 indexed citations
5.
Cochet, Sylvie, Emilie‐Fleur Gautier, Philippe Chafey, et al.. (2021). Altered Ca2+ Homeostasis in Red Blood Cells of Polycythemia Vera Patients Following Disturbed Organelle Sorting during Terminal Erythropoiesis. Cells. 11(1). 49–49. 7 indexed citations
6.
Varghese, Leila N., Myriam Oufadem, Bénédicte Neven, et al.. (2021). CALR mutant protein rescues the response of MPL p.R464G variant associated with CAMT to eltrombopag. Blood. 138(6). 480–485. 3 indexed citations
7.
Dessen, Philippe, Marie Cambot, Iléana Antony‐Debré, et al.. (2021). Dual role of EZH2 in megakaryocyte differentiation. Blood. 138(17). 1603–1614. 8 indexed citations
8.
Lambert, Juliette, Joseph Saliba, Carolina Calderón, et al.. (2021). PPARγ agonists promote the resolution of myelofibrosis in preclinical models. Journal of Clinical Investigation. 131(11). 6 indexed citations
9.
Maslah, Nabih, Valérie Edmond, Bruno Cassinat, et al.. (2020). JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML. The Journal of Experimental Medicine. 218(2). 19 indexed citations
10.
Cacemiro, Maira da Costa, Valérie Edmond, Delphine Muller, et al.. (2020). Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN. Nature Communications. 11(1). 4886–4886. 26 indexed citations
11.
Kepp, Oliver, Peng Liu, Liwei Zhao, Isabelle Plo, & Guido Kroemer. (2020). Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis. OncoImmunology. 9(1). 1792037–1792037. 16 indexed citations
12.
Balayn, Nathalie, Larissa Lordier, Francesco Baschieri, et al.. (2019). Disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia by increasing RhoA activity. Blood. 133(16). 1778–1788. 25 indexed citations
13.
Čokić, Vladan P., et al.. (2017). Quantitative Proteome Heterogeneity in Myeloproliferative Neoplasm Subtypes and Association with JAK2 Mutation Status. Molecular Cancer Research. 15(7). 852–861. 4 indexed citations
14.
Marty, Caroline, C. Pecquet, Harini Nivarthi, et al.. (2015). Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis. Blood. 127(10). 1317–1324. 180 indexed citations
15.
Chachoua, Ilyas, C. Pecquet, Mira El-Khoury, et al.. (2015). Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants. Blood. 127(10). 1325–1335. 223 indexed citations
16.
Antony‐Debré, Iléana, Nathalie Balayn, Dominique Bluteau, et al.. (2014). Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia. Blood. 125(6). 930–940. 71 indexed citations
17.
Martin‐Lannerée, Severine, Imen Najjar, Isabelle Plo, et al.. (2013). Differential Contributions of STAT5A and STAT5B to Stress Protection and Tyrosine Kinase Inhibitor Resistance of Chronic Myeloid Leukemia Stem/Progenitor Cells. Cancer Research. 73(7). 2052–2058. 57 indexed citations
18.
Marty, Caroline, Catherine Lacout, Nathalie Droin, et al.. (2013). A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression. Leukemia. 27(11). 2187–2195. 136 indexed citations
19.
Plo, Isabelle, Corentin Laulier, Laurent Gauthier, et al.. (2008). AKT1 Inhibits Homologous Recombination by Inducing Cytoplasmic Retention of BRCA1 and RAD51. Cancer Research. 68(22). 9404–9412. 108 indexed citations
20.
Plo, Isabelle, Mayuka Nakatake, Laurent Malivert, et al.. (2008). JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders. Blood. 112(4). 1402–1412. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frédéric Larbret Breakdown of academic impact, for papers by Stany Chrétien Breakdown of academic impact, for papers by Claudia Scholl Breakdown of academic impact, for papers by Shannon Elf Breakdown of academic impact, for papers by Martin Ruthardt Breakdown of academic impact, for papers by Matthew R. Warr Breakdown of academic impact, for papers by Rebecca J. Chan Breakdown of academic impact, for papers by Jacqueline E. Damen Breakdown of academic impact, for papers by Hanna S. Radomska Breakdown of academic impact, for papers by Diana Linnekin
Rankless by CCL
2026